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Sir, We report 2 cases of patients who underwent a) left pyelolithotomy and b) right radical nephrectomy. After a standard general anethesia they received a left and a right TMQLB respectively, for perioperative analgesia. After preoperative evaluation and obtaining fitness for surgery, a standard general anesthesia with a right transmuscular quadratus lumborum block (TMQLB) for perioperative analgesia was planned. An informed consent was obtained from the patient for the same. The quadratus lumborum plane (QLP) was identified with a curvilinear ultrasound (US) probe (8-5 MHz, Sonosite Inc), as described by Børglum et al. [1] An 18-G Tuohy's needle was inserted in QLP and 20 ml of 0.2% ropivacaine was injected. The needle tip was placed at the mid part of the anterior quadratus lumborum fascia (AQLF), as visualized on the US. The distance from the skin to AQLF or the anterior thoracolumbar fascia (ATLF) was 4.5 cm on left and 4.9 cm on right. On injecting 25 ml of 0.25% bupivacaine, there was an elliptical swelling that projected anteriorly towards the peritoneum and posteriorly towards the junction of the psoas major and quadratus lumborum muscle. There was no breach of the AQ L F/ ATLF and there was a predictable downward movement of psoas major muscle. Thereafter, a 20-G catheter was placed in the ATLF at 5-7 cm in both. A bolus of 5 ml of local anesthetic (LA) was injected and the spread observed again under US.
Intraoperatively we requested the surgeon to demonstrate the catheter in the QLP. As shown in Figure 1a , we could see the catheter coiled in the anterior thoracolumbar space and did not breach the quadratus lumborum fascia. As depicted in Figure 1b the catheter had perforated the ATLF.
We feel that LA spread and the catheter placement in QLP is not always predictable. We could observe coiling and perforation of the catheter in the ATLF. The drug and the catheter takes the path of least resistance. The drug spread depends on the direction of catheter, the final position of the tip of the catheter, and the dynamics within the QLP. The dermatomes covered by the block depends on the course taken by catheter and the final spread of LA. [2] [3] [4] Consent was taken from the patient for obtaining images for publication in medical journal without disclosing the name for academic purpose.
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Journey of a quadratus lumborum plane catheter: Is it important to know? A novel technique of ultrasound-guided glossopharyngeal nerve block to relieve cancer pain Sir, Conventional glossopharyngeal nerve block (GPN) involves topical, intraoral, and peristyloid approach. However, ineffectiveness in deeper pathology, risk of vascular injury, and inadvertent block of closely associated other cranial nerves are their potential drawbacks. [1] We report the first successful use of a novel technique of GPN block, which is potentially devoid of such complications.
A 55-year-old man presented with uncontrolled throbbing and burning pain due to an unresectable cancer of the posterior one-third of the tongue [ Figure 1 ]. It was 10/10 on the numeric pain rating scale (NRS) best relieved to 8/10 with oral medications (immediate release morphine 60 mg every 4 h and ibuprofen 400 mg every 8 h). The patient consented to this new technique of distal GPN block with potentially less chance of complications after refusing consent for peristyloid technique. This technique was first described by Azman et al. [2] in cadavers and normal volunteers. High-frequency ultrasound probe (6-15 MHz) was kept with its medial tip on lateral cornu of hyoid bone in transverse plane, and then the lateral tip of probe was rotated toward angle of mandible. Once the facial vessels in the intermuscular plane and the two muscle groups (superficial group of posterior belly of digastric and stylohyoid, and deep group consisting of styloglossus and stylopharyngeus) are identified, a 22-G lumbar puncture needle was advanced till it reached just superficial to the pharyngeal constrictor muscle (identified by the dirty air shadow of pharynx) [ Figure 2 ]. After a successful diagnostic dose of 2-mL 0.5% ropivacaine, 1.2 mL of dexamethasone, 4 mg/dL, and 1 mL of 0.5% ropivacaine was injected after 24 h of the initial injection. The procedure was uneventful with no immediate complications. NRS at 24 h, 48 h, 4 days, 1 week, and 2 weeks postinjection were 2/10, 2/10, 3/10, 5/10, and 6/10, respectively.
In our case, the nerve block was at distal level just before GPN enters the pharynx. Only visceral sensory fibres of the GPN supplying the pharyngeal mucosa are affected at this level, preserving other innervations of the GPN. About 2 mL of nerve blocking agent is the maximum volume of drug the para-pharyngeal space would take without spreading to adjacent areas. [2] Dexamethasone has been reported to prolong duration of a nerve block and reduce severity of pain likely due to modulation of local inflammation and reduction in blood. [3] We refrained from using neurolytic agents such as alcohol or phenol because of its potential side effects on adjacent structures with a potential risk of pharyngeal perforation. [4] However, a safer agent meant that the duration of pain relief was relatively short, with adequate relief lasting for just about a week.
This case demonstrated that ultrasound-guided distal GPN block technique was technically feasible in bringing short lasting excellent cancer pain relief in our patient. Further trials are needed to validate the same in a larger cohort.
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